Skip to the page

Data / Form D filings / Glycologix, Inc.

Glycologix, Inc.: Form D filings

Glycologix, Inc., a technology company in Beverly, MA, filed 4 Form D notices with the SEC between 2022 and 2025. The latest, on December 29, 2025, reports $800,000 sold of a $1 million offering to 30 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
100 CUMMINGS CENTER, SUITE 451C, Beverly, MA, 01915
Phone
(617) 480-2536
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1903671

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 29, 2025New notice$1,000,000$800,000$200,00030Dec 12, 2025sec.gov
Apr 9, 2024New notice$1,500,000$1,500,00048Apr 5, 2024sec.gov
May 23, 2023New notice$1,750,000$1,100,687$649,31325May 15, 2023sec.gov
Jan 10, 2022New notice$3,000,000$1,800,000$1,200,00028Dec 24, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
George AdaniyaDirector
Daniel DeardorfExecutive Officer, Director
Martha FarmerDirector
Michael MarshDirector
Michael ChesterDirector

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Dec 29, 2025 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Glycologix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.